Preparation of siRNA encapsulated nanoliposomes suitable for siRNA delivery by simply discontinuous mixing

Biochim Biophys Acta Biomembr. 2018 Jun;1860(6):1318-1325. doi: 10.1016/j.bbamem.2018.02.027. Epub 2018 Mar 6.

Abstract

Previously a scalable and extrusion-free method has been developed for efficient liposomal encapsulation of DNA by twice stepwise mixing of lipids in ethanol and DNA solution using T-shape mixing chamber. In this study, we prepared nanoliposomes encapsulating siRNA by simply discontinuous mixing of lipids in ethanol/ether/water mixture and acidic siRNA solution without use of special equipment. The simple mixing siRNA/liposomal particles (siRNA/SMLs) prepared using ethanol/ether/water (3:1:1) mixture showed 120.4 ± 20.2 nm particle size, 0.174 ± 0.033 polydispersity and 86.5 ± 2.76% siRNA encapsulation rate. In addition, the SMLs almost completely protected the encapsulated siRNA from RNase A digestion. Coupling of anti-human epidermal growth factor receptor (EGFR) Fab' to siRNA/SMLs enhanced EGFR-specific cell penetration of SMLs and induced siRNA dependent gene silencing. Unexpectedly, the Cy5.5-labeled Fab' showed almost no in vivo targeting to the xenografted A549 tumors in SCID-NOD mice. However, multiple injection of the unmodified siRNA/SMLs accumulated in the tumors and induced siRNA-dependent in vivo gene silencing. These results demonstrate that the siRNA/SMLs can be used as a siRNA delivery tool for gene therapy.

Keywords: Fab′ preparation and labeling; Gene silencing; Simple mixing nanoliposome; Target specific delivery; siRNA encapsulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Compounding
  • Drug Delivery Systems / methods*
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Immunoglobulin Fab Fragments
  • Liposomes*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Molecular Targeted Therapy
  • NIH 3T3 Cells
  • Nanostructures*
  • Neoplasm Proteins / antagonists & inhibitors
  • Particle Size
  • RNA Interference
  • RNA, Small Interfering / administration & dosage*
  • RNA, Small Interfering / pharmacokinetics
  • Xenograft Model Antitumor Assays

Substances

  • Immunoglobulin Fab Fragments
  • Liposomes
  • Neoplasm Proteins
  • RNA, Small Interfering
  • EGFR protein, human
  • ErbB Receptors